New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 17, 2014
11:09 EDTNUS, HLF, RGROptions with increasing implied volatility: NUS HLF RGR
News For NUS;HLF;RGR From The Last 14 Days
Check below for free stories on NUS;HLF;RGR the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 18, 2014
09:54 EDTNUSNu Skin mentioned cautiously by Bronte Capital
Reference Link
August 13, 2014
14:04 EDTHLFAckman will continue Herbalife short position as needed, Bloomberg reports
Bill Ackman's hedge-fund Pershing Square said most of the Herbalife contracts it holds will expire next year and that it will extend their terms by "paying additional premiums if it is necessary to do so," according to Bloomberg, citing Ackman's quarterly letter to investors. In the letter, Ackman said that the cost of holding a short position in options of Herbalife has dropped "substantially" after the company canceled its dividend, the report noted. Reference Link
11:21 EDTHLFAckman says Herbalife may be unable to refinance 2016 credit, Bloomberg reports
Subscribe for More Information
06:39 EDTNUSNu Skin volatility flat as shares near15-month low
Nu Skin August call option implied volatility is at 45, September and December is at 44; compared to its 26-week average of 47 according to Track Data, suggesting decreasing price movement.
August 8, 2014
16:46 EDTHLFCapital Research reports 10.1% passive stake in Herbalife
Subscribe for More Information
August 7, 2014
10:00 EDTNUSOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
06:08 EDTNUSNu Skin orice target lowered to $70 from $110 at Deutsche Bank
Deutsche Bank lowered its price target for Nu Skin shares to $70 saying the regulatory overhang "continue to wreak havoc on the company’s important China business." The firm, however, says comparisons ease next year and that inventory can be worked down or written off. Deutsche keeps a Buy rating on Nu Skin following yesterday's Q2 results. Note the stock was downgraded this morning at JPMorgan to Neutral.
05:48 EDTNUSNu Skin downgraded to Neutral from Overweight at JPMorgan
JPMorgan downgraded Nu Skin to Neutral saying the underlying business is weaker than it expected with little visibility following the company's Q2 results. The firm cut its price target for shares in half to $50 from $100. Nu Skin closed yesterday down $11.40 to $46.52 after reporting Q2 results.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use